Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > On his last day at Theralase, Shawn Shirazi

<< Previous

Bullboard Posts

Next >>

Post by Eoganachton Aug 20, 2021 11:21am

344 Views

Post# 33739752

On his last day at Theralase, Shawn Shirazi

...is shaking the dust from his feet. He was a CEO with no skin in the game. He sold the entirety of his 5,000 share holding for the princely sum of $950.

Filing Details

Issuer Name Theralase Technologies Inc.

Insider Name Shirazi, Shawn

Relationship as filed with regulators 5 - Senior Officer of Issuer

Transaction ID 3792011

Filing Date Aug 20, 2021

Transaction Date Aug 20, 2021

Security Type Common Shares

Transaction Nature 10 - Acquisition or disposition in the public market

Ownership Type Direct Ownership

# or Value Acquired or Disposed of -5,000

Unit Price or Exercise Price $0.190